Wikidata

(Q65380121)

English

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
RE-SONATE (English)
0 references
title
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long-term Prevention of Recurrent Symptomatic Proximal Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis or Pulmonary Embolism. (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Czech Republic
0 references
Estonia
0 references
Germany
0 references
Italy
0 references
Latvia
0 references
Lithuania
0 references
Netherlands
0 references
New Zealand
0 references
Poland
0 references
Singapore
0 references
South Africa
0 references
Sweden
0 references
Switzerland
0 references
Thailand
0 references
start time
November 2007
0 references
end time
February 2011
0 references
number of participants
1,353
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65380121&oldid=2237483732"